133 related articles for article (PubMed ID: 10806476)
1. Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1.
Xu Y; Zhu K; Hong G; Wu W; Baudhuin LM; Xiao Y; Damron DS
Nat Cell Biol; 2000 May; 2(5):261-7. PubMed ID: 10806476
[TBL] [Abstract][Full Text] [Related]
2. The G protein-coupled receptor GPR4 suppresses ERK activation in a ligand-independent manner.
Bektas M; Barak LS; Jolly PS; Liu H; Lynch KR; Lacana E; Suhr KB; Milstien S; Spiegel S
Biochemistry; 2003 Oct; 42(42):12181-91. PubMed ID: 14567679
[TBL] [Abstract][Full Text] [Related]
3. Novel clusters of receptors for sphingosine-1-phosphate, sphingosylphosphorylcholine, and (lyso)-phosphatidic acid: new receptors for "old" ligands.
Kostenis E
J Cell Biochem; 2004 Aug; 92(5):923-36. PubMed ID: 15258916
[TBL] [Abstract][Full Text] [Related]
4. Sphingosylphosphorylcholine and lysophosphatidylcholine are ligands for the G protein-coupled receptor GPR4.
Zhu K; Baudhuin LM; Hong G; Williams FS; Cristina KL; Kabarowski JH; Witte ON; Xu Y
J Biol Chem; 2001 Nov; 276(44):41325-35. PubMed ID: 11535583
[TBL] [Abstract][Full Text] [Related]
5. Sphingosylphosphorylcholine stimulates human monocyte-derived dendritic cell chemotaxis.
Lee HY; Shin EH; Bae YS
Acta Pharmacol Sin; 2006 Oct; 27(10):1359-66. PubMed ID: 17007744
[TBL] [Abstract][Full Text] [Related]
6. Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A.
Kabarowski JH; Zhu K; Le LQ; Witte ON; Xu Y
Science; 2001 Jul; 293(5530):702-5. PubMed ID: 11474113
[TBL] [Abstract][Full Text] [Related]
7. Previously postulated "ligand-independent" signaling of GPR4 is mediated through proton-sensing mechanisms.
Tobo M; Tomura H; Mogi C; Wang JQ; Liu JP; Komachi M; Damirin A; Kimura T; Murata N; Kurose H; Sato K; Okajima F
Cell Signal; 2007 Aug; 19(8):1745-53. PubMed ID: 17462861
[TBL] [Abstract][Full Text] [Related]
8. The signalling profile of recombinant human orexin-2 receptor.
Tang J; Chen J; Ramanjaneya M; Punn A; Conner AC; Randeva HS
Cell Signal; 2008 Sep; 20(9):1651-61. PubMed ID: 18599270
[TBL] [Abstract][Full Text] [Related]
9. Antiproliferative effect of sphingosylphosphorylcholine in thyroid FRO cancer cells mediated by cell cycle arrest in the G2/M phase.
Afrasiabi E; Blom T; Balthasar S; Törnquist K
Mol Cell Endocrinol; 2007 Aug; 274(1-2):43-52. PubMed ID: 17606321
[TBL] [Abstract][Full Text] [Related]
10. Identification of an EDG7 variant, HOFNH30, a G-protein-coupled receptor for lysophosphatidic acid.
Fitzgerald LR; Dytko GM; Sarau HM; Mannan IJ; Ellis C; Lane PA; Tan KB; Murdock PR; Wilson S; Bergsma DJ; Ames RS; Foley JJ; Campbell DA; McMillan L; Evans N; Elshourbagy NA; Minehart H; Tsui P
Biochem Biophys Res Commun; 2000 Jul; 273(3):805-10. PubMed ID: 10891327
[TBL] [Abstract][Full Text] [Related]
11. Sphingosylphosphorylcholine and lysosulfatide have inverse regulatory functions in monocytic cell differentiation into macrophages.
Yamamoto H; Naito Y; Okano M; Kanazawa T; Takematsu H; Kozutsumi Y
Arch Biochem Biophys; 2011 Feb; 506(1):83-91. PubMed ID: 21081108
[TBL] [Abstract][Full Text] [Related]
12. Tonic inhibitory role for cAMP in alpha(1a)-adrenergic receptor coupling to extracellular signal-regulated kinases 1/2.
Jiao X; Gonzalez-Cabrera PJ; Xiao L; Bradley ME; Abel PW; Jeffries WB
J Pharmacol Exp Ther; 2002 Oct; 303(1):247-56. PubMed ID: 12235258
[TBL] [Abstract][Full Text] [Related]
13. The bioactive lipid sphingosylphosphorylcholine induces differentiation of mouse embryonic stem cells and human promyelocytic leukaemia cells.
Kleger A; Busch T; Liebau S; Prelle K; Paschke S; Beil M; Rolletschek A; Wobus A; Wolf E; Adler G; Seufferlein T
Cell Signal; 2007 Feb; 19(2):367-77. PubMed ID: 16978842
[TBL] [Abstract][Full Text] [Related]
14. Identification of human OGR1, a novel G protein-coupled receptor that maps to chromosome 14.
Xu Y; Casey G
Genomics; 1996 Jul; 35(2):397-402. PubMed ID: 8661159
[TBL] [Abstract][Full Text] [Related]
15. Sphingosylphosphorylcholine generates reactive oxygen species through calcium-, protein kinase Cdelta- and phospholipase D-dependent pathways.
Jeon ES; Kang YJ; Song HY; Im DS; Kim HS; Ryu SH; Kim YK; Kim JH
Cell Signal; 2005 Jun; 17(6):777-87. PubMed ID: 15722202
[TBL] [Abstract][Full Text] [Related]
16. Role of EGF receptor transactivation in phosphoinositide 3-kinase-dependent activation of MAP kinase by GPCRs.
Shah BH; Neithardt A; Chu DB; Shah FB; Catt KJ
J Cell Physiol; 2006 Jan; 206(1):47-57. PubMed ID: 15920762
[TBL] [Abstract][Full Text] [Related]
17. Activation of MAPKs by G protein-coupled receptors.
Crespo P; Gutkind JS
Methods Mol Biol; 2004; 250():203-10. PubMed ID: 14755090
[No Abstract] [Full Text] [Related]
18. Sphingosylphosphorylcholine enhances calcium entry in thyroid FRO cells by a mechanism dependent on protein kinase C.
Afrasiabi E; Blom T; Ekokoski E; Tuominen RK; Törnquist K
Cell Signal; 2006 Oct; 18(10):1671-8. PubMed ID: 16490345
[TBL] [Abstract][Full Text] [Related]
19. Sphingosylphosphorylcholine-induced interleukin-6 production is mediated by protein kinase C and p42/44 extracellular signal-regulated kinase in human dermal fibroblasts.
Kwon YB; Lee YS; Sohn KC; Piao YJ; Back SJ; Seo YJ; Suhr KB; Park JK; Kim CD; Lee JH
J Dermatol Sci; 2007 May; 46(2):91-9. PubMed ID: 17321112
[TBL] [Abstract][Full Text] [Related]
20. The multi-functional role of sphingosylphosphorylcholine.
Nixon GF; Mathieson FA; Hunter I
Prog Lipid Res; 2008 Jan; 47(1):62-75. PubMed ID: 18042469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
